Journals / Klinik Psikofarmakoloji Bülteni / 2012 / Cilt: 22 - Sayı: 2

Acute generalized exanthematous pustulosis associated with the use of quetiapine

Ketiyapin kullanımına bağlı akut generalize ekzantematöz püstüloz

Pages
194–197
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this paperwe presented a case who had an adverse drug reaction and was diagnosed with AGEP associated with the useof quetiapine.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The use of antipsychotics can cause dermatologicalside effects.
📊
Key Findings & Data:Acute generalized exanthematouspustulosis (AGEP) developing with an acute initialpustular eruption is a cutaneous reaction which maybe seen particularly after the use of carbamazepineand penicillin.
💡
Conclusion & Impact:In this paperwe presented a case who had an adverse drug reaction and was diagnosed with AGEP associated with the useof quetiapine.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

The use of antipsychotics can cause dermatologicalside effects. Acute generalized exanthematouspustulosis (AGEP) developing with an acute initialpustular eruption is a cutaneous reaction which maybe seen particularly after the use of carbamazepineand penicillin. Although dermatological side effectsdue to antipsychotic use have been reported in theliterature, as far as we know there has not been a caseof AGEP related to the use of quetiapine. In this paperwe presented a case who had an adverse drug reaction and was diagnosed with AGEP associated with the useof quetiapine.

Özet

Antipsikotik kullanımı sonrası dermatalojik yan etkilergörmek mümkündür. Akut yaygın ekzantematöz püstü loz (AGEP) ani başlayan, püstüler döküntü ile seyreden,özellikle karbamazepin ve penisilin kullanımını sonrasıgörülen nadir bir kutanöz reaksiyondur. Antipsikotikyan etkilerine dair olgular bildirilmesine karşın, bildiği miz kadarıyla ketiyapin kulanımına bağlı AGEP olgusuliteratürde bulunmamaktadır. Bu yazıda ilaç reaksiyonuöyküsü olan ve ketiyapin kullanımına bağlı AGEP tanı sıyla takip edilen bir olgu sunulmuştur.

🔖

Cite This Article

ÇAĞLAR, H. P. N., KALKAN, H. S. (2022). Acute generalized exanthematous pustulosis associated with the use of quetiapine. Klinik Psikofarmakoloji Bülteni, Cilt: 22 - Sayı: 2, 194–197. https://ajindex.com/articles/574448

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Warnock JK, Morris DW. Adverse cutaneous reactionsantipsychotics. Am J Clin Dermatol 2002; 3(9):629-36. Litt JZ. Litt’s drug eruption reference manual. 11th edn. LondonTaylor&Francis, 2005. P.555-607.
  2. Hernandez-Salazar A, Rosales SP, Rangel-Frausto S, Criollo EArcher-Dubon C, Orozco-Topete R. Epidemiology of adverse cutaneous drug reactions. A prospectivestudy in hospitalized patients. Arch Med Res 2006; 37(7):899-902.
  3. Apaydin R, Bilen N, Dokmeci S, Bayramgürler D, Yıldırım GDrug eruptions: a study including all inpatients and outpatients aa dermatology clinic of auniversity hospital. J Eur Acad DermatoVenereol 2000;14(6):518-20.
  4. Britschgi M, Steiner UC, Schmid S,,Depta JP, Senti G, Bircher A, et al. T-cell involvement indrug induced acute generalized exanthematous pustulosis. JClin Invest 2001; 107(11):1433-41.
  5. Beylot C, Bioulac P, Doutre MS. Acute generalized exanthematic pustuloses (four cases). Ann Dermatol Venereol 1980; 107(1-2):37- 48. Beylot C, Doutre MS, Beylot-Barry M. Acute generalized exanthematous pustulosis. Semin Cutan Med Surg 1996; 15:244-9. Belda JWFerolla ACJ. Acute generalized exanthematous pustulosis (AGEP). Case report. Rev Inst Med Trop Sao Paulo 2005; 47(3):171-6.
  6. Dolar N, Tüzün Y. Akut generalize ekzantematöz püstüloz. Dermatose 2005; 44:173-5.
  7. Adışen E, Karaca F, Güner M,A. Dermatolojide İlaç Reaksiyonları. Türk Dermatoloji Dergisi 2008; 2:1-5.
  8. Sharma VK, Sethuraman G,reactions: clinical pattern andChandigarh, India. J PostgradKumar B. Cutaneous adverse drug causative agents-a 6 year series from Med 2001; 47(2): 95-9.
  9. Puavilai S, Choonhakarn C. Drug eruptions in Bangkok: a 1-year study at Ramathibodi Hospital. Int J Dermatol 1998; 37(10):747-51.
  10. Sushma M, Noel MV, Ritika MC, James J, Guido S. Cutaneous adverse drug reactions: a 9-year study from a South Indian Hospital. Pharmacoepidemiol Drug Saf 2005; 14(8):567-70.
  11. Bigby M, Jick S, Jick H, Arndt K. Drug-induced cutaneous reactions. A report from the Boston Collaborative Drug Surveillance Program on 15,438 consecutive inpatients, 1975 to 1982. JAMA 1986; 256(24):3358-63.
  12. Desarkar P, Nizamie SH. Risperidone-induced erythema multiforme minor. Br J Clin Pharmacol 2006; 62(4):504-5.
  13. Gregoriou S, Karagiorga T, Stratigos A, Volonakis K, Kontochristopoulos G, Rigopoulos D. Photo-onycholysis caused by olanzapine and aripiprazole. J Clin Psychopharmacol 2008; 28(2):219-20.
  14. Swensen E, Ravasia S. Ziprasidone-induced lupus erythematosus. Can J Psychiatry 2004; 49(6):413-4.
  15. Duggal MK, Singh A